Acadia Pharmaceuticals Inc SEC filings ACAD
Acadia Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Nov 9, 2010. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 10, 2026 | — |
| S-3 | Shelf registration | May 9, 2025 | — |
| S-8 | Employee stock plan registration | Sep 23, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | Aug 20, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 POS | Filing | May 29, 2024 | — |
| S-8 | Employee stock plan registration | May 29, 2024 | — |
| S-8 | Employee stock plan registration | Feb 7, 2023 | — |
| S-8 | Employee stock plan registration | Aug 9, 2022 | — |
| S-3ASR | Automatic shelf registration | May 25, 2022 | — |
| S-3ASR | Automatic shelf registration | Aug 25, 2020 | — |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 424B5 | Prospectus supplement | Sep 18, 2019 | — |
| 424B5 | Prospectus supplement | Sep 17, 2019 | — |
| S-8 | Employee stock plan registration | Aug 2, 2019 | — |
| S-3ASR | Automatic shelf registration | May 3, 2019 | — |
| 424B5 | Prospectus supplement | Nov 28, 2018 | — |
| 424B5 | Prospectus supplement | Nov 26, 2018 | — |
| S-3ASR | Automatic shelf registration | Nov 26, 2018 | — |
| S-8 | Employee stock plan registration | Aug 14, 2018 | — |
| S-8 | Employee stock plan registration | Aug 8, 2017 | — |
| S-8 | Employee stock plan registration | Aug 12, 2016 | — |
| 424B5 | Prospectus supplement | Aug 10, 2016 | — |
| 424B5 | Prospectus supplement | Aug 8, 2016 | — |
| S-3ASR | Automatic shelf registration | Apr 1, 2016 | — |
| 424B5 | Prospectus supplement | Jan 7, 2016 | — |
| 424B5 | Prospectus supplement | Jan 5, 2016 | — |
| S-8 | Employee stock plan registration | Nov 12, 2015 | — |
| S-8 | Employee stock plan registration | Aug 5, 2014 | — |
| 424B5 | Prospectus supplement | Mar 5, 2014 | — |
| 424B5 | Prospectus supplement | Mar 3, 2014 | — |
| S-3ASR | Automatic shelf registration | Mar 3, 2014 | — |
| S-8 | Employee stock plan registration | Aug 6, 2013 | — |
| 424B5 | Prospectus supplement | May 15, 2013 | — |
| 424B5 | Prospectus supplement | May 14, 2013 | — |
| S-3 | Shelf registration | Dec 21, 2012 | — |
| S-8 | Employee stock plan registration | Aug 8, 2012 | — |
| 424B5 | Prospectus supplement | Mar 30, 2012 | — |
| S-3 | Shelf registration | Dec 23, 2011 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Aug 19, 2011 | — |
| S-8 | Employee stock plan registration | Aug 10, 2011 | — |
| 424B5 | Prospectus supplement | Apr 11, 2011 | — |
| S-3 | Shelf registration | Jan 14, 2011 | — |
Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACAD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1070494
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.